Researchers at the University of Colorado School of Medicine Anschutz Medical Campus in Aurora, Colorado, sought to measure the effect that an online decision aid could have on easing stress and building knowledge about when driving is no longer safe.
"Particularly in pediatrics, we are trained to screen patients with JIA for celiac disease, but this study points to the possible bidirectional association and the importance of maintaining a clinical suspicion for JIA and RA among established celiac disease patients," Marisa Stahl, MD, assistant professor of pediatrics and associate program director of the pediatric gastroenterology, hepatology, and nutrition fellowship training program at the University of Colorado School of Medicine in Aurora, told Medscape Medical News.
"Determining the true incidence of celiac disease (CD) is not possible without nonbiased screening for the disease. This is because many cases occur with neither a family history nor with classic symptoms," write Edwin Liu, MD, a pediatric gastroenterologist at the Children's Hospital Colorado Anschutz Medical Campus and director of the Colorado Center for Celiac Disease, and colleagues.
We're fortunate today to have Dr. John Corboy as our guest. He started the first one of these trials, and it has just recently been completed. He'll talk to us about that. Dr. Corboy is a professor of neurology, executive vice chair of neurology at the University of Colorado School of Medicine, and medical director of the Rocky Mountain MS Center. Welcome, Dr. Corboy.
Corey Lyon, DO, vice chair for clinical affairs in the Department of Family Medicine at the University of Colorado School of Medicine, says primary care doctors are playing a bigger role in providing psychiatric care and can offer emotional support for these patients as part of an emphasis on "whole-person care."
Kevin D. Deane, MD, PhD, associate professor of medicine and chair in rheumatology research at the University of Colorado Anschutz Medical Campus in Aurora, advises physicians to keep in mind other conditions linked with increased risk for severe COVID-19, including advanced age, heart, lung, or kidney problems, and autoimmune diseases.
The survey was conducted by researchers at the University of Colorado School of Medicine, who collected data from 58,408 healthcare workers in 208 organizations between April and December 2020. Respondents were asked, "Due to…COVID-19, I am experiencing concerns about childcare," and subsequently assessed their CCS on a scale of 1, "not at all," to 4, "a great extent," with a score of 3 or 4 representing high CCS.
In this series, recognized experts from the University of Colorado's Severe Asthma Clinic and Comprehensive Lung and Breathing Program explain the implications of recently approved monoclonal antibodies for the treatment of severe eosinophilic asthma. They explain the value of recognizing the heterogeneity of asthma and the need for correct diagnosis of this troubling subtype as early as possible. Although new and emerging therapies show a promising reduction in disease burden, specialists say that equity and access issues still thwart their efforts to provide these benefits to every patient.
